Skip to main content
. Author manuscript; available in PMC: 2007 Oct 1.
Published in final edited form as: Pharmacol Biochem Behav. 2007 Apr 3;87(1):1–10. doi: 10.1016/j.pbb.2007.03.014

Figure 5.

Figure 5

Startle magnitude on P-ALONE (0 dB over background) and prepulse+PULSE trials after infusion of either vehicle or the highest AMPH dose (40 μg) in rats in which startle magnitude was not altered after AMPH infusion into the NACcm. Data shows that AMPH selectively elevates startle magnitude on prepulse+PULSE trials in SD rats, reflecting a loss of sensorimotor gating (* p < 0.05 vs. vehicle dose).